ReviewFrontiers in immunology2025

Targeting hypoxia-inducible factor 1α in chronic graft-versus-host disease to enhance graft-versus-leukemia responses: implications for nanotherapeutics.

Yimin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.